Skip to content
DraconiticResearch
Search Sources API
190,332 studies31 sourcesUpdated 42 min ago
PreprintAll rights reservedbioRxiv

AT1R-Selective Negative Allosteric Modulator Targeting the Epitope for Pathogenic Autoantibody Activation

  • K. D. Singh
  • T. R. Pardhi
  • T. J. Harford
  • L. Laishram
  • T. Ravi
  • R. Desnoyer
  • A. P. Maroo
  • W. W. H. Tang
  • S. S. Karnik1
  1. 1Cleveland Clinic Lerner College of Medicine at Case Western Reserve University
Read full textPDFDOICite

Related

  1. The α2‐Subunit Preferring GABA Positive Allosteric Modulator, N‐Desmethyl‐Clobazam in Peripheral Neuropathic Pain Patients: Results of a Phase IIa Randomised Placebo‐Controlled Ascending Dose Study
    M. Besson, A. Matthey, Y. Daali +4
    European journal of pain (London, England)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Discovery of GluA3 preferring AMPA receptor positive allosteric modulator BRD3290
    C. Greaves, W. E. Martenis, S. D. Nelson +16
    bioRxivPreprintAll rights reservedFull textPharmacology & toxicologybioRxiv
  3. A Phase 1 Study of MK-1942, a Negative Allosteric Modulator of mGluR2, in Healthy Japanese to Flexibly Assess Factors Including CYP2C19 Phenotype.
    Chihiro Hasegawa, Yohei Doi, Tomona Hirano +10
    Clinical and translational sciencePeer-reviewedCC BY-NCFull textPharmacology & toxicologyEurope PMC
  4. DIFFERENTIAL ACTIVATION OF G-PROTEIN SUBTYPES BY DOPAMINE D1 RECEPTOR ALLOSTERIC MODULATION
    A. M. Nguyen, H. Umaoka, H. Yano
    bioRxivPreprintCC BY-NC-NDFull textPharmacology & toxicologybioRxiv
  5. A Case of Familial Chylomicronemia Syndrome Caused by a Novel Homozygous GPIHBP1 Mutation Successfully Treated with the Selective PPARα Modulator Pemafibrate
    Tomoko Otsuki, Yumi Chung, Yusuke Kawachi +8
    Journal of Atherosclerosis and ThrombosisPeer-reviewedCC BY-NC-SAFull textCardiovascular medicineJ-STAGE

Cite

BibTeXRIS
BibTeX
@misc{singh2026at1rselective,
  title = {{AT1R-Selective Negative Allosteric Modulator Targeting the Epitope for Pathogenic Autoantibody Activation}},
  author = {K. D. Singh and T. R. Pardhi and T. J. Harford and L. Laishram and T. Ravi and R. Desnoyer and A. P. Maroo and W. W. H. Tang and S. S. Karnik},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.12.758523},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.12.758523v1},
}
RIS
TY  - UNPB
TI  - AT1R-Selective Negative Allosteric Modulator Targeting the Epitope for Pathogenic Autoantibody Activation
AU  - K. D. Singh
AU  - T. R. Pardhi
AU  - T. J. Harford
AU  - L. Laishram
AU  - T. Ravi
AU  - R. Desnoyer
AU  - A. P. Maroo
AU  - W. W. H. Tang
AU  - S. S. Karnik
PY  - 2026
DA  - 2026/10/12
PB  - bioRxiv
DO  - 10.64898/2026.10.12.758523
UR  - https://www.biorxiv.org/content/10.64898/2026.10.12.758523v1
ER  -